Cannabidiol as a potential treatment for psychosis
Psychotic disorders such as schizophrenia are heterogeneous and often debilitating conditions that contribute substantially to the global burden of disease. The introduction of dopamine D2 receptor antagonists in the 1950s revolutionised the treatment of psychotic disorders and they remain the mains...
Saved in:
Main Authors: | Cathy Davies (Author), Sagnik Bhattacharyya (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2019-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acceptability of cannabidiol in patients with psychosis
by: Edward Chesney, et al.
Published: (2022) -
The therapeutic potential of purified cannabidiol
by: Saoirse Elizabeth O'Sullivan, et al.
Published: (2023) -
Baclofen Withdrawal-Induced Psychosis in the Setting of Renal Insufficiency
by: Guilmette Amanda, et al.
Published: (2022) -
Treatment of postpartum psychosis in breastfeeding females
by: Lauren Chaney, PharmD, BCPP
Published: (2024) -
Ambulatory treatment in a patient with postpartum psychosis
by: Maria Mercedes Arrate Negret, et al.
Published: (2016)